Times to Diagnosis, Staging, and Treatment of Head and Neck Cancer Before and During COVID-19

• Published in: OTO open : the official open access journal of the American Academy of Otolaryngology--Head and Neck Surgery Foundation Vol. 5; no. 4; pp. 2473974X211059429 - n/a
• Main Authors: Yao, Peter, Cooley, Victoria, Kuhel, William, Tassler, Andrew, Banuchi, Victoria, Long, Sallie, Savenkov, Oleksandr, Kutler, David Ivan
• Format: Journal Article
• Language: English
• Published: Los Angeles, CA SAGE Publications 01.10.2021; John Wiley & Sons, Inc; Wiley
• Subjects: Coronaviruses; COVID-19; diagnosis delay; Head & neck cancer; head and neck cancer; Medical diagnosis; Original Research; Otolaryngology; Pandemics; staging delay; treatment delay; COVID-19; staging delay; head and neck cancer; treatment delay; diagnosis delay
• ISSN: 2473-974X; 2473-974X
• DOI: 10.1177/2473974X211059429

Objective The coronavirus disease 2019 (COVID-19) pandemic has reduced the demand for, and supply of, head and neck cancer services. This study compares the times to diagnosis, staging, and treatment of head and neck cancers before and during the COVID-19 pandemic. Study Design Retrospective cohort study. Setting Tertiary academic medical center in New York City (NYC). Methods The times to diagnosis, staging, and treatment of head and neck cancer for patients presenting to the clinics of 4 head and neck oncology surgeons with newly diagnosed head and neck cancers were compared between pre–COVID-19 and COVID-19 periods. Results Sixty-eight patients in the pre–COVID-19 period and 26 patients in the COVID-19 period presented with newly diagnosed head and neck cancer. Patients in the COVID-19 group had a significantly longer time to diagnosis than the pre–COVID-19 group after adjustment for age and cancer diagnosis (P = .02; hazard ratio [HR], 0.54; 95% CI, 0.32-0.92). Patients in the pre–COVID-19 and COVID-19 groups had no statistically significant differences in time to staging (P > .9; HR, 1.01; 95% CI, 0.58-1.74) or time to treatment (P = .12; HR, 1.55; 95% CI, 0.89-2.72). Conclusion This study found that time to diagnosis for head and neck cancers was delayed during a COVID-19 period compared to a pre–COVID-19 period. However, there was no evidence of delays in time to staging and time to treatment during the COVID-19 period. Our results prompt further investigations into the factors contributing to diagnostic delays but provide reassurance that despite COVID-19, patients were receiving timely staging and treatment for head and neck cancers.